Cite this DOI
10.46243/jst.2021.v6.i3.pp75-79 · A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets
APA (7th edition)
Khachane, A. A. (2021). A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets. *Journal of Science & Technology*, *06*(03), 75–79. https://doi.org/10.46243/jst.2021.v6.i3.pp75-79
⬇ text Italics are shown as *asterisks* in plain text — the journal or book title and the volume.
BibTeX
@article{khachane2021review,
author = {Khachane, Amit A.},
title = {{A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets}},
journal = {Journal of Science \& Technology},
year = {2021},
month = {may},
volume = {06},
number = {03},
pages = {75--79},
publisher = {Longman Publishers},
issn = {2456-5660},
doi = {10.46243/jst.2021.v6.i3.pp75-79},
url = {https://doi.org/10.46243/jst.2021.v6.i3.pp75-79},
language = {en},
abstract = {The aim of this study was to evaluate the effect of increasing nifedipine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anginal pain and hypertension. Nifedipine undergoes first pass metabolism in liver and gut wall which has oral bioavailability of 43-77\%. Sublingual dosage form bypasses the metabolism of the nifedipine in liver and offers a fast relieve from anginal pain and hypertension. An attempt has been made to prepare fast dissolving tablets of nifedipine using super distintegrants like Cross Carmellose Sodium, Sodium Starch Glycolate, CrosPovidone. Three different groups of formulations (A, R, and V) with variation in tablet excipients were prepared by direct compression method.Tablet weight variation, hardness, friability, drug content, disintegration time and dissolution time were evaluated for each formulation and found satisfactory. The studied sublingual tablet group V shows a lesser T50\% compared to commercial oral tablet. The Group V also indicates the fast dissolution and disintegration rate of the optimized nifedipine sublingual tablet, which is prerequisite for rapid management of anginal and hypertension diseases.}
}RIS (EndNote, Zotero, Mendeley)
TY - JOUR TI - A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets AU - Khachane, Amit A. JO - Journal of Science & Technology PY - 2021 DA - 2021/05/27/ VL - 06 IS - 03 SP - 75 EP - 79 PB - Longman Publishers SN - 2456-5660 LA - en AB - The aim of this study was to evaluate the effect of increasing nifedipine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anginal pain and hypertension. Nifedipine undergoes first pass metabolism in liver and gut wall which has oral bioavailability of 43-77%. Sublingual dosage form bypasses the metabolism of the nifedipine in liver and offers a fast relieve from anginal pain and hypertension. An attempt has been made to prepare fast dissolving tablets of nifedipine using super distintegrants like Cross Carmellose Sodium, Sodium Starch Glycolate, CrosPovidone. Three different groups of formulations (A, R, and V) with variation in tablet excipients were prepared by direct compression method.Tablet weight variation, hardness, friability, drug content, disintegration time and dissolution time were evaluated for each formulation and found satisfactory. The studied sublingual tablet group V shows a lesser T50% compared to commercial oral tablet. The Group V also indicates the fast dissolution and disintegration rate of the optimized nifedipine sublingual tablet, which is prerequisite for rapid management of anginal and hypertension diseases. DO - 10.46243/jst.2021.v6.i3.pp75-79 UR - https://doi.org/10.46243/jst.2021.v6.i3.pp75-79 ER -
CSL-JSON
{
"type": "article-journal",
"id": "10.46243/jst.2021.v6.i3.pp75-79",
"DOI": "10.46243/jst.2021.v6.i3.pp75-79",
"URL": "https://doi.org/10.46243/jst.2021.v6.i3.pp75-79",
"title": "A Review on Formulation and Evaluation of Nifedipine Sublingual Tablets",
"source": "Smart Scholars DOI Registry",
"container-title": "Journal of Science & Technology",
"author": [
{
"family": "Khachane",
"given": "Amit A."
}
],
"issued": {
"date-parts": [
[
2021,
5,
27
]
]
},
"volume": "06",
"issue": "03",
"page": "75-79",
"publisher": "Longman Publishers",
"language": "en",
"abstract": "The aim of this study was to evaluate the effect of increasing nifedipine load on the characteristics of fast-disintegrating sublingual tablets for the potential emergency treatment of anginal pain and hypertension. Nifedipine undergoes first pass metabolism in liver and gut wall which has oral bioavailability of 43-77%. Sublingual dosage form bypasses the metabolism of the nifedipine in liver and offers a fast relieve from anginal pain and hypertension. An attempt has been made to prepare fast dissolving tablets of nifedipine using super distintegrants like Cross Carmellose Sodium, Sodium Starch Glycolate, CrosPovidone. Three different groups of formulations (A, R, and V) with variation in tablet excipients were prepared by direct compression method.Tablet weight variation, hardness, friability, drug content, disintegration time and dissolution time were evaluated for each formulation and found satisfactory. The studied sublingual tablet group V shows a lesser T50% compared to commercial oral tablet. The Group V also indicates the fast dissolution and disintegration rate of the optimized nifedipine sublingual tablet, which is prerequisite for rapid management of anginal and hypertension diseases.",
"ISSN": "2456-5660"
} ⬇ .json What citeproc and reference managers read; the DOI system hands it out for Accept: application/vnd.citationstyles.csl+json, and so does this registry's resolver.
From the record as registered (version 2) — the record and its history. Programs: https://registry.smartscholars.in/api.php?action=cite&doi=10.46243%2Fjst.2021.v6.i3.pp75-79 gives all four in one JSON answer.
